Objective
To better understand neurotrauma outcome variability, we’re studying nerve cells made from patients’ own blood using induced pluripotent stem cell (iPSC) technology. The data found in this study will hopefully allow us to predict rehabilitation outcomes as well as better understand the individual patient factors affecting the recovery process.
Who Can Participate
has suffered neurotrauma and undergone acute inpatient rehabilitation at the Shirley Ryan AbilityLab.
Compensation
Not Provided
Age Range
over the age of 18
